Robin Lynn Scheer-mineer, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 261 N Ashbrook Cir # A, Lakeside Park, KY 41017 Phone: 859-907-8043 |
News Archive
Investment in screening programs that target the pre-Medicare population, individuals aged between 50 and 64, is needed to reduce the costs of colorectal cancer in the Medicare program, according to the results of a new study, "Cost-Savings to Medicare from Increased Colorectal Cancer Screening in the Pre-Medicare Population," unveiled today at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas.
Strange Glow tells the story of man's encounter with radiation, and how mankind has been transformed by the experience. The book focuses on a health-centric perspective "that seeks to remove some of the mystery and misunderstanding that surrounds radiation," says Jorgensen, director of the Health Physics and Radiation Protection Graduate Program, and chair of Georgetown's Radiation Safety Committee.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted 13 to 2 to recommend that the FDA approve BENLYSTA (belimumab) for the treatment of autoantibody-positive patients with active systemic lupus erythematosus (SLE).
Bristol-Myers Squibb Company announced today that belatacept, an investigational selective T cell co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of eight clinical presentations related to kidney transplantation at the American Transplant Congress, being held May 1 - 5 in San Diego.
› Verified 8 days ago